Bananas may be the next candidate to deliver a bite-sized vaccine for hepatitis B virus (HBV) in developing countries.
In the forthcoming June 1 issue of Biotechnology Progress, co-published by the American Chemical Society and the American Institute of Chemical Engineers, researchers in India review the efforts to genetically engineer plants as biofactories for vaccine production and focus on transferring genes to produce HBV vaccine.
There are already 350 million carriers of hepatitis B worldwide, with one million new cases diagnosed each year. cheap cymbalta
Plant-based production of an oral hepatitis B vaccine has advantages over the injectable vaccine. Bananas, potatoes, lettuce, carrots, and tobacco have been successfully engineered to produce HBV vaccines.